Men with secondary hypogonadism and clinical or biochemical findings suggestive of a sellar mass or hypothalamic-pituitary disease, an elevated serum prolactin concentration, a very low serum total testosterone concentration, or serum gonadotropin concentration below the lower limit of normal should undergo sellar imaging. The gene discussed is PRL; the disease is hypogonadotropic hypogonadism.